Clinical Study
Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer
Table 2
Response therapeutic for lymphedema treatment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The mean difference between the beginning and end of treatment was analyzed using Wilcoxon test; Kolmogrov-Smirnov test > 0,05. Volume tracking < initial volume. Volume tracking > initial volume. Volume tracking = initial volume. CI: confidence interval; : number of patients. |